price
RX
NASDAQ · RXST
RxSight, Inc.
Healthcare · Medical - Devices
$4.59
Down-$0.21 (-4.38%)
Updated Nov 4, 2026, 11:23 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 539.04M
- P/E ratio
- -16.56
- Dividend yield
- 0.00%
- 52-week range
- $4.40 – $13.22
- Volume
- 1.2M
- Avg. volume
- 777.3K
Price performance · RXST
RXST price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
RXST closed at $4.59 after 21 trading sessions, down 1.29% for the selected period.
- Last close
- $4.59
- Period change
- -1.29%
- Period low
- $4.51
- Period high
- $5.08
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $4.78 | $4.78 | $4.545 | $4.59 | 1.2M |
| Nov 2, 2026 | $4.91 | $5.01 | $4.79 | $4.80 | 757.42K |
| Oct 30, 2026 | $5.06 | $5.065 | $4.845 | $4.87 | 468.49K |
| Oct 29, 2026 | $4.97 | $5.19 | $4.92 | $5.05 | 841.6K |
| Oct 28, 2026 | $4.76 | $4.94 | $4.75 | $4.90 | 787.84K |
| Oct 27, 2026 | $4.97 | $5.045 | $4.87 | $4.90 | 588.69K |
| Oct 26, 2026 | $4.97 | $5.095 | $4.889 | $4.93 | 451.46K |
| Oct 23, 2026 | $5.07 | $5.105 | $5.01 | $5.02 | 326.8K |
| Oct 22, 2026 | $4.89 | $5.09 | $4.84 | $5.08 | 393.23K |
| Oct 21, 2026 | $4.87 | $5.04 | $4.77 | $4.90 | 577.12K |
| Oct 20, 2026 | $4.71 | $4.92 | $4.65 | $4.88 | 453.92K |
| Oct 19, 2026 | $4.46 | $4.77 | $4.45 | $4.69 | 743.69K |
| Oct 16, 2026 | $4.70 | $4.83 | $4.495 | $4.51 | 1.04M |
| Oct 15, 2026 | $4.59 | $4.71 | $4.55 | $4.67 | 611.17K |
| Oct 14, 2026 | $4.46 | $4.55 | $4.40 | $4.52 | 826.7K |
| Oct 13, 2026 | $4.68 | $4.77 | $4.445 | $4.53 | 694.86K |
| Oct 12, 2026 | $4.85 | $4.98 | $4.55 | $4.66 | 834.56K |
| Oct 9, 2026 | $4.83 | $4.94 | $4.75 | $4.81 | 522.34K |
| Oct 8, 2026 | $4.74 | $4.86 | $4.68 | $4.85 | 938.31K |
| Oct 7, 2026 | $4.61 | $4.95 | $4.61 | $4.80 | 842.15K |
| Oct 6, 2026 | $4.76 | $4.76 | $4.60 | $4.65 | 623.01K |
Latest RXST news
The latest Smart Investors Daily articles mentioning RXST.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…

